Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy

NCT02302547 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

224

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: triple therapy
DRUG: dual therapy

Sponsor

University Hospital, Tours

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]